Correlation Between Reviva Pharmaceuticals and Sarepta Therapeutics

Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Sarepta Therapeutics, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Sarepta Therapeutics.

Diversification Opportunities for Reviva Pharmaceuticals and Sarepta Therapeutics

0.1

Correlation Coefficient

Reviva Pharmaceuticals  Sarepta Therapeutics

Average diversification

The 3 months correlation between Reviva and Sarepta is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Sarepta Therapeutics go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Sarepta Therapeutics

Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to generate 5.24 times more return on investment than Sarepta Therapeutics. However, Reviva Pharmaceuticals is 5.24 times more volatile than Sarepta Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Sarepta Therapeutics is currently generating about -0.19 per unit of risk. If you would invest  124.00  in Reviva Pharmaceuticals Holdings on November 28, 2024 and sell it today you would earn a total of  10.00  from holding Reviva Pharmaceuticals Holdings or generate 8.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Reviva Pharmaceuticals Holding  vs.  Sarepta Therapeutics

Reviva Pharmaceuticals

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Reviva Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Sarepta Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sarepta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Reviva Pharmaceuticals and Sarepta Therapeutics

The main advantage of trading using opposite Reviva Pharmaceuticals and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.

The idea behind Reviva Pharmaceuticals Holdings and Sarepta Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.